McCarthy Daniel Joseph 4
4 · Evolent Health, Inc. · Filed Aug 26, 2024
Insider Transaction Report
Form 4
McCarthy Daniel Joseph
PRESIDENT
Transactions
- Exercise/Conversion
Class A Common Stock
2024-08-22$24.75/sh+4,550$112,613→ 222,502 total - Sale
Class A Common Stock
2024-08-22$30.00/sh−16,693$500,790→ 205,809 total - Sale
Class A Common Stock
2024-08-23$32.00/sh−6,469$207,008→ 192,340 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2024-08-22−4,550→ 0 totalExercise: $24.75Exp: 2027-08-01→ Class A Common Stock (4,550 underlying) - Sale
Class A Common Stock
2024-08-22$33.00/sh−7,000$231,000→ 198,809 total - Sale
Class A Common Stock
2024-08-23$33.00/sh−4,000$132,000→ 188,340 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]The Class A Common Stock Options exercised vested on August 1, 2018, August 1, 2019, August 1, 2020, and August 1, 2021.